Real-world data on throat cancer treatments could shape future studies
NCT ID NCT06771674
First seen Nov 01, 2025 · Last updated May 12, 2026 · Updated 14 times
Summary
This study looked at 662 people with HPV-positive throat cancer that had spread or come back. Researchers checked how patients were treated with pembrolizumab or nivolumab (with or without chemo) in real-world clinics. The goal was to gather information to help design better future clinical trials, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OROPHARYNGEAL SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cardinal Health
Dublin, Ohio, 43017, United States
Conditions
Explore the condition pages connected to this study.